These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25214391)

  • 1. Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects.
    Franke AG; Bagusat C; Rust S; Engel A; Lieb K
    Eur Arch Psychiatry Clin Neurosci; 2014 Nov; 264 Suppl 1():S83-90. PubMed ID: 25214391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement.
    Franke AG; Lieb K; Hildt E
    PLoS One; 2012; 7(6):e40047. PubMed ID: 22768218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Case of Pharmacological Neuroenhancement: Medical, Judicial and Ethical Aspects from a German Perspective.
    Franke AG; Northoff R; Hildt E
    Pharmacopsychiatry; 2015 Nov; 48(7):256-64. PubMed ID: 26252723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological cognitive enhancement from a perspective of misuse and addiction].
    Franke AG; Soyka M
    Fortschr Neurol Psychiatr; 2015 Feb; 83(2):83-90. PubMed ID: 25723772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of university students using stimulants for cognitive enhancement: a pilot study].
    Franke AG; Schwarze CE; Christmann M; Bonertz C; Hildt E; Lieb K
    Psychiatr Prax; 2012 May; 39(4):174-80. PubMed ID: 22318482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of coffee, caffeinated drinks and caffeine tablets for cognitive enhancement in pupils and students in Germany.
    Franke AG; Christmann M; Bonertz C; Fellgiebel A; Huss M; Lieb K
    Pharmacopsychiatry; 2011 Nov; 44(7):331-8. PubMed ID: 21993866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological neuroenhancement and brain doping : Chances and risks].
    Franke AG; Lieb K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):853-9. PubMed ID: 20700786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Prescription Drugs, Recreational Drugs, and "Soft Enhancers" for Cognitive Enhancement among Swiss Secondary School Students.
    Liakoni E; Schaub MP; Maier LJ; Glauser GV; Liechti ME
    PLoS One; 2015; 10(10):e0141289. PubMed ID: 26505633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration.
    Teter CJ; McCabe SE; LaGrange K; Cranford JA; Boyd CJ
    Pharmacotherapy; 2006 Oct; 26(10):1501-10. PubMed ID: 16999660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Use of Caffeinated Substances by Surgeons for Cognitive Enhancement.
    Franke AG; Bagusat C; McFarlane C; Tassone-Steiger T; Kneist W; Lieb K
    Ann Surg; 2015 Jun; 261(6):1091-5. PubMed ID: 25072440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Doping for the brain].
    Iglseder B
    Z Gerontol Geriatr; 2018 Feb; 51(2):143-148. PubMed ID: 29209802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life context of pharmacological academic performance enhancement among university students--a qualitative approach.
    Hildt E; Lieb K; Franke AG
    BMC Med Ethics; 2014 Mar; 15():23. PubMed ID: 24606831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
    Schilt T; de Win MM; Jager G; Koeter MW; Ramsey NF; Schmand B; van den Brink W
    Psychol Med; 2008 Sep; 38(9):1309-17. PubMed ID: 17988417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of college students with attention-deficit hyperactivity disorder symptoms who misuse their medications.
    Jardin B; Looby A; Earleywine M
    J Am Coll Health; 2011; 59(5):373-7. PubMed ID: 21500055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential for misuse and abuse of medications in ADHD: a review.
    Clemow DB; Walker DJ
    Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Changing Drug Culture: Use and Misuse of Cognition-Enhancing Drugs.
    Albertson TE; Chenoweth JA; Colby DK; Sutter ME
    FP Essent; 2016 Feb; 441():25-9. PubMed ID: 26881770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine.
    Repantis D; Bovy L; Ohla K; Kühn S; Dresler M
    Psychopharmacology (Berl); 2021 Feb; 238(2):441-451. PubMed ID: 33201262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of methylphenidate misuse in a university student sample.
    Barrett SP; Darredeau C; Bordy LE; Pihl RO
    Can J Psychiatry; 2005 Jul; 50(8):457-61. PubMed ID: 16127963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder.
    Turner DC; Clark L; Dowson J; Robbins TW; Sahakian BJ
    Biol Psychiatry; 2004 May; 55(10):1031-40. PubMed ID: 15121488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey.
    McCabe SE; Knight JR; Teter CJ; Wechsler H
    Addiction; 2005 Jan; 100(1):96-106. PubMed ID: 15598197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.